Statement of Ownership (sc 13g)
August 13 2021 - 4:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[X] Rule 13d-1(b)
[_] Rule 13d-1(c)
[_] Rule 13d-1(d)
__________
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 30233M503
CUSIP No. 30233M503
|
|
|
|
Item 3.
|
If This Statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
|
|
|
|
|
|
(a)
|
[_]
|
Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).
|
|
|
|
|
|
(b)
|
[_]
|
Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
|
|
|
|
|
|
(c)
|
[_]
|
Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
|
|
|
|
|
|
(d)
|
[_]
|
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
(e)
|
[X]
|
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
(f)
|
[_]
|
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
(g)
|
[X]
|
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
(h)
|
[_]
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
|
|
|
|
|
|
(i)
|
[_]
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
|
|
|
|
(j)
|
[_]
|
Group, in accordance with s.240.13d-1(b)(1)(ii)(J).
|
|
|
|
|
|
|
|
|
Item 4.
|
Ownership.
|
|
|
|
|
|
|
|
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
|
|
|
|
|
|
(a)
|
Amount beneficially owned:
|
|
|
|
|
|
Armistice Capital, LLC – 2,916,101
Steven Boyd – 2,916,101
|
|
(b)
|
Percent of class:
|
|
|
|
|
|
Armistice Capital, LLC – 19.8%
Steven Boyd – 19.8%
|
The percentage of Shares reported to be beneficially owned by the Reporting Persons are based on 12,619,256 Shares outstanding as of August 11, 2021, as reported in the Issuer’s Form 10-Q filed with the SEC on August 12,
2021. Of the 2,916,101 Shares beneficially owned by the Reporting Persons, 2,131,101 of such Shares are issuable upon exercise of warrants beneficially owned by the Reporting Persons. The amount of Shares issuable upon exercise of warrants
beneficially owned by the Reporting Persons are limited due to the beneficial ownership limitations applicable to certain of the warrants.
Armistice Capital, LLC (“Armistice Capital”) is the investment manager of Armistice Capital Master Fund Ltd. (the "Master Fund"), the direct holder of the Shares, and pursuant to an Investment Management Agreement,
Armistice Capital exercises voting and investment power over the securities of the Issuer held by the Master Fund and thus may be deemed to beneficially own the securities of the Issuer held by the Master Fund. Mr. Boyd, as the managing member of
Armistice Capital, may be deemed to beneficially own the securities of the Issuer held by the Master Fund. The Master Fund specifically disclaims beneficial ownership of the securities of the Issuer directly held by it by virtue of its inability
to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of
them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.01 per share, of EyeGate Pharmaceuticals, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such
Statement.
Dated: August 13, 2021
AB Corporate Bond ETF (NASDAQ:EYEG)
Historical Stock Chart
From Aug 2024 to Sep 2024
AB Corporate Bond ETF (NASDAQ:EYEG)
Historical Stock Chart
From Sep 2023 to Sep 2024